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ABSTRACT 
In Indian System of Medicine the bark of Symplocos racemosa belonging to family Symplocaceae is used for the treatment of asthma, bronchitis, dropsy, 
arthritis, inflammation, ulcers, menorrhagia and hepatic ailments. The objective of the present study was to investigate the analgesic and anti-inflammatory 
potential of the bark of Symplocos racemosa. The formalin induced paw licking and tail flick models were used to study the analgesic activity and carrageenan 
induced hind paw edema model was used to study anti-inflammatory activity of ethanolic and aqueous extracts of the bark. Wistar strain albino rats with 200 
mg/kg dose were used for both studies. Diclofenac sodium (5 mg/kg) was used as the standard drug. In tail flick test the increase in the reaction time was 
significant (P < 0.01) with ethanolic extract of the bark of Symplocos racemosa as compared to the control group.  Acute edema in the left hind paw of the 
animals  was induced by  sub  plantar injection of 0.1 ml (1%) carregeenan suspension in normal saline.  The ethanolic extract of the bark of Symplocos 
racemosa very significantly (P <0.001) reduced the paw edema in carrageenan treated rats. The effect was maximum at 3 hr after the carrageenan injection. 
The significant suppression of inflammation during the whole experimental period indicates the long duration of action of the ethanolic extract of the bark.  
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INTRODUCTION 
The world is facing an explosive increase in the incidence of 
many  systemic  diseases  and  hence  cost  effective 
complementary therapies are needed.  Medicinal plants have 
been the subject of intense research due to their potential as 
sources of commercial drugs or as lead compounds in drug 
development.  Inflammation  is  a  local  response  of  living 
mammalian tissues to injury. It is a body defense reaction in 
order to eliminate or limit the spread of injurious agent. There 
are various components of an inflammatory reaction that can 
contribute  to  the  associated symptoms and  tissue  injury. 
Edema  formation,  leukocyte  infiltration  and  granuloma 
formation represent such components of inflammation
1.  The 
drugs which are used presently for the management of pain 
and  inflammatory  conditions  are  either  narcotics  or  non 
narcotics  (NSAIDS),  and  have  known  toxic  and  lethal 
effects
2.  About  34-46%  of  the  users  of  NSAIDs  usually 
sustain some gastrointestinal damage due to the inhibition of 
the protective cyclo-oxygenase enzyme in gastric mucosa 
3.  
On the contrary, herbal medicines with good absorption, less 
toxicity, and easy availability have been used since ancient 
times
4.  According  to  WHO  about  80%  of  the  world 
population  still  rely  mainly  on herbal  remedies
5-6.     It  is 
therefore,  essential  that  efforts  be  made  to  introduce  new 
medicinal  plants,  to  develop  cheaper,  effective  and  safe 
analgesic and anti-inflammatory   drugs
7. 
Symplocos  racemosa (Symplocaceae)  commonly  known  as 
“Lodhra” in Sanskrit or “Rodhra, is a small, evergreen tree 
upto  6  m  tall.  It  is  found  in  the  plains  and  lower  hills 
throughout North and East India 
8. The bark is dark grey and 
rough;  and  is  useful  in  diarrhea,  dysentery,  eye  diseases, 
fever, ulcer, scorpion sting, diabetes, and liver disorders
9. It 
has  been  scientifically  reported  as  an  antimicrobial 
10, 
anticancer
11  and  has  beneficial  effects  in  gynaecological 
disorders
12.  Phytochemical  investigations  of  the  bark  of 
Symplocos  racemosa  have  revealed  the  presence  of 
monomethyl  pelargonidin  glucosides  (I  &II),  loturine, 
colloturine,  loturidine,  reducing  sugars,  oxalic  acid, 
phytosterol  and  flavon  glycosides.  The  present  study  was 
therefore  aimed  at  evaluating  the  analgesic  and  anti-
inflammatory activity of the bark of Symplocos racemosa. 
 
MATERIALS AND METHODS 
Animals 
Male / Female  Albino rats of Wistar strain weighing 120 – 
200g  obtained  from  the  Department  of  Pharmacy,  MJRP, 
were used for the experiment. The animals were housed in 
cages  under  standard  lab  conditions  (12:12  hr  light  /  dark 
cycles  at  25±2˚C,  RH55±10%).  They  had  free  access  to 
standard pellet diet and water ad libitum. The animals were 
acclimatized  at  least  one  week  prior  to  experiment.  All 
experiments  were  approved  by  Institutional  Animal  Ethics 
Committee. 
Plant Materials and Extracts 
The  bark  of  Symplocos  racemosa  was  procured  from 
Shantikunj,  Haridwar  and  was  authenticated  by  the 
Department of Botany, Ambah Post Graduate College, Jiwaji 
University, Gwalior. The authenticated plant materials were 
shade  dried  and  powered  coarsely.  The  coarsely  powdered 
drugs  were  extracted  separately  in  soxhlet  apparatus  in 
sufficient volume of redistilled water and ethanol at 45-48˚C
 
for  18  hrs.  The  filtrates  were  collected  and  evaporated  to 
dryness at 40˚C
 on rotary evaporator. The solid masses were 
collected carefully and weighed. Their yields were calculated 
and then stored in sealed (air tight) glass bottles at 4˚C
 for 
further experimental work. 
Treatment protocol 
The  animals  were  divided  into  four  groups  of  six  animals 
each. Group I served as control and received the suspension 
of  1%  CMC  in  distilled  water.    Group  II  received  the 
reference drug diclofenac sodium 5mg/kg. Group III and IV 
received 200 mg/kg of ethanolic and aqueous extracts of SR 
by oral route (p.o.). All the test drugs were suspended in1% 
CMC and were administered in a volume of 5 ml/kg body 
weight. 
Formalin induced paw licking model 
The  Formalin  test  comprises  the  early  and  late  phase 
assessment of the analgesic effect as described by Hunskaar Sharma Satish Kumar et al. IRJP 2013, 4 (2) 
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&  Hole
13.  One  hour  after  drug  administration  by  the  oral 
route, 20 µl of 1% formalin was injected subcutaneously sub-
plantar  in  the  right  hind  paw.  Then  the  duration  of  paw 
licking as an index of nociception was recorded in periods of 
0 to 5 minutes (early phase) and 15 to 30 minutes (late phase) 
after formalin injection. 
Tail flick model 
In  this  model  Nichrome  wire  analgesiometer  was  used 
14. 
Individually the tail of each rat was placed over the radiant 
heat source of the apparatus and the tail withdrawal from the 
heat  (flicking  response)  was  taken  as  the  end  point. 
Analgesic  activity  was  assessed  by  observing  the  reaction 
time in the treated groups. Following the administration of 
drugs, the reaction time was noted at 0, 30, 60, 90 and 120 
min. A cut of time of 15 seconds was considered to avoid 
tissue injury. 
Carrageenan induced paw edema 
This  test  was  performed  as  per  the  method  described  by 
Winter et al
15. The animals were fasted for 16 hours but water 
was allowed ad libitum
16.  Acute edema in left hind paws of 
the rats was induced by the sub-plantar injection of 0.1 ml of 
freshly prepared (1% w/v) carrageenan suspension in normal 
saline 1h after the drug administration. The paw volume was 
measured before and 1, 2, 3 and 4 h after the carrageenan 
injection. The results were expressed as mean ± SEM. The 
statistical analysis of data was done by the Student's t-test and 
one-way  Analysis  of  Variance  (ANOVA)  followed  by 
Dunnet’s  test.  The  results  were  considered  statistically 
significant at P < 0.05. 
 
TABLE I: EFFECT OF ETHANOLIC AND AQUEOUS EXTRACTS OF SYMPLOCOS RACEMOSA ON EARLY AND LATE PHASE OF THE 
FORMALIN TEST 
Group  Dose 
(mg/kg) 
Early phase 
Licking time (s)            % inhibition 
Late phase 
Licking time (s)             % inhibition 
Control  -  72.33±3.80    89.50±7.62   
Reference Drug 
(Diclofenac sodium) 
5  50.50±4.27**  30.18  35.83±3.37***  59.96 
SRE  200  65.50±4.88  9.44  66.50±4.79*  25.69 
SRA  200  69.33±5.20  4.14  69.00±4.64*  22.90 
Values are expressed as mean±SEM, n = 6 in each group. *P< 0.05, **P< 0.01, ***P< 0.001 compared with control. 
 
TABLE II: EFFECT OF ETHANOLIC AND AQUEOUS EXTRACTS OF SYMPLOCOS RACEMOSA ON RADIANT HEAT INDUCED TAIL 
FLICK RESPONSE IN RATS. 
Groups  Dose 
(mg/kg) 
After 0 min   
(sec) 
After 30 min   
(sec) 
After 60 min   
(sec) 
After 90 min   
(sec) 
After 120 min  
 (sec) 
Control  -  4.19 ±0.23  4.04±0.26  4.02±0.34  4.42±0.32  3.89±0.34 
Diclofenac sodium  5  4.47±0.35  4.97±0.35  8.11±0.65***  7.19±0.50***  9.33±0.58*** 
SRE  200  4.16±0.28  4.27±0.31  4.72±0.36  6.64±0.50**  5.35±0.37* 
SRA  200  3.91±0.27  4.17±0.26  4.54±0.29  5.48±0.47  4.63v0.35 
Values are expressed as mean±SEM, n = 6 in each group. *P< 0.05, **P< 0.01, ** *P< 0.001 compared with control. 
 
TABLE III: EFFECT OF ETHANOLIC AND AQUEOUS EXTRACTS OF SYMPLOCOS RACEMOSA ON CARRAGEENAN-INDUCED PAW 
EDEMA IN RATS 
Groups  Dose (mg/kg)  1
st hr  2
nd hr  3
rd hr  4
th hr 
Control    0.62±0.04  0.77±0.05  0.77±0.04  0.67±0.04 
Diclofenac sodium  5  0.53±0.03  0.49±0.04**  0.45±0.03***  0.41±0.03*** 
SRE  200  0.55±0.03  0.61±0.04*  0.49±0.03***  0.53±0.03* 
SRA  200  0.59±0.03  0.63±0.04  0.58±0.04*  0.62±0.04 
Values are expressed as mean±SEM, n = 6 in each group. *P< 0.05, **P< 0.01, ** *P< 0.001 compared with control. 
 
RESULTS 
Formalin induced paw licking model 
The formalin induced paw licking model was used to study 
the analgesic effects during early and late phase   (Table 1). 
The  administration  of  standard  drug  diclofenac  sodium 
significantly  (P<0.01)  inhibited  the  licking  response.  The 
ethanolic and aqueous extracts of Symplocos racemosa failed 
to produce any significant suppression in the licking response 
during the early phase of formalin test. In the late phase of 
formalin  test,  the  administration  of  standard  drug  highly 
significantly (P<0.001) inhibited the paw licking response as 
compared to the  control group.  The  ethanolic  and aqueous 
extracts  of  Symplocos  racemosa  significantly  (P<0.05) 
suppressed the paw licking in the late phase as compared to 
control group.  
Tail flick model 
In  the  tail  flick  test  the  ethanolic  extract  of  Symplocos 
racemosa produced a reaction time of 4.27±0.31, 4.72±0.36, 
6.64±0.50,  5.35±0.37  seconds  after  30,  60,  90  and  120 
minutes  respectively  (Table  2).  The  reaction  time  for  the 
same period with control group was found to be 4.04±0.26, 
4.02±0.34, 4.42±0.32, 3.89±0.34 seconds respectively.  The 
reaction time for diclofenac sodium treated group was found 
to  be  4.97±0.35,  8.11±0.65,  7.19±0.50,  9.33±0.58  seconds 
after 30, 60, 90 and 120 minutes respectively. The reaction 
time with aqueous extract of Symplocos racemosa  for the 
same  period  was  found  to  be  4.17±0.26,  4.54±0.29, 
5.48±0.47  and  4.63±0.35  seconds  respectively.  The  above 
results show that the increase in reaction time in ethanolic 
extract treated group was found to be  significant after 90 min 
( P <0.01 ) and 120 minutes ( P <0.05 )  respectively; and non 
significant after 30 and 60  minutes as compared to  control 
groups. The increase in reaction time in standard drug treated 
group was found to be highly significant (P <0.001) after 60, 
90 and 120 minutes.  The increase in reaction time in aqueous 
extract of Symplocos racemosa treated group was found to be 
non  significant  after  30  and  60,  90  and  120  minutes 
respectively.  The  increase  in  reaction  time  was  highest  in  
standard drug treated group and was seen until the last phase 
observation  (120  minutes).  In  the  ethanolic  extract  and 
standard drug treated groups, the maximum effects were seen 
after 90 and 120 minutes respectively. 
Carrageenan induced paw edema 
Development of paw edema was observed in both control and 
treated groups after carrageenan injection. Thickness of the 
paw  was  found  to  be  increased  initially  upon  injection  of 
carrageenan due to volume effect. Difference in the thickness 
of the rat paw edema was further increased during the time Sharma Satish Kumar et al. IRJP 2013, 4 (2) 
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interval of 1h – 4h in   control group. When compared with 
the control, the treatment with ethanolic extract of SR was 
found to produce significant suppression of inflammation at 
2,  3  and  4  h  after  carrageenan  injection  (Table  3).  When 
compared with the control, the treatment with aqueous extract 
of SR showed significant (P<0.05) suppression of edema at 3 
h. 
When  compared  with  control,  the  treatment  with  standard 
drug significantly suppressed the edema at 2h (P<0.01) and at 
3  and  4h  (P<0.001).  When  compared  with  ethanolic  and 
aqueous  extract  of  Symplocos  racemosa,  the  anti- 
inflammatory activity with the standard drug treatment was 
more  powerful  and  pronounced.  When  compared  with 
aqueous  extract,  the  ethanolic  extract  produced  more 
powerful  and  pronounced  anti-inflammatory  activity.  The 
aqueous extract exhibited significant (P<0.05) suppression of 
edema  at  3h.  The  results  clearly  show  that  the  anti-
inflammatory activity of standard drug and ethanolic extract 
of Symplocos racemosa treated groups was seen at 2, 3 and 
4h.  
 
DISCUSSION 
In  the  present  investigation  anti-inflammatory  activity  of 
ethanolic and aqueous extracts of Symplocos racemosa was 
studied  by  using  inhibition  of  carrageenan  induced 
inflammation which is one of the most feasible methods to 
screen  anti-inflammatory  agents.  Carrageenan-induced 
inflammation  is  a  useful  experimental  model  of  acute 
inflammation  for  detecting  orally  active  anti-inflammatory 
agents
17.  Edema  formation  in  the  rat  paw  is  a  biphasic 
response. The first phase is mediated through the release of 
histamine, serotonin, and kinins, whereas the second phase is 
due  to  the  release  of  prostaglandin  and  slow  reacting 
substances
18. 
The  ethanolic  and  aqueous  extract  of  Symplocos  racemosa 
significantly reduced the paw edema. In this experiment the 
suppression  of  inflammation  may  be  due  to  PG  and  kinin 
synthesis/release inhibition and antihistamine activities. The 
maximum  inflammation  is  seen  approximately  three  hours 
post  the  carrageenan  injection,  after  which  it  begins  to 
decline23.  
The formalin model was developed >30 years ago to assess 
pain and evaluate analgesic drugs in laboratory animals. In 
this  test,  a  dilute  (0.5–5%)  formalin  solution  (in  which 
formaldehyde is the active ingredient) is injected into the paw 
of a rodent, and pain-related behaviors are assessed over two 
temporally  distinct  phases
19-20.  In  the  present  study  the 
analgesic  activity  of  ethanolic  and  aqueous  extracts  of 
Symplocos racemosa was evaluated by formalin induced paw 
licking and the tail flick model. The persistent pain model of 
formalin induced hind paw licking was used in the study. The 
first  phase  of  pain  is  attributed  to  the  direct  activation  of 
nociceptors and primary afferent fibres by formalin, causing 
the release of bradykinin and tachykinins
21-22. This phase is 
inhibited by opioid analgesics. The second phase is due to an 
inflammatory reaction caused by tissue injury leading to the 
release of histamine, serotonin, prostaglandin and excitatory 
amino  acids 
23-24.  This  late  phase  is  inhibited  by  non  –
steroidal anti inflammatory drugs and opioid analgesics 
The tail flick model is used to evaluate the analgesic agents 
acting  through  central  nervous  system.  In  this  method  a 
nichrome wire is used to produce pain. In the present study 
ethanolic  and  aqueous  extracts  of  Symplocos  racemosa 
significantly inhibited the paw licking in the late phase. In the 
tail  flick  test  the  ethanolic  extract  of  Symplocos  racemosa 
significantly  increased  the  reaction  time.  The  results  of 
analgesic  and  anti-inflammatory  activities  of  ethanolic 
extracts  of  Symplocos  racemosa  are  comparable  with 
standard drug diclofenac sodium. 
 
CONCLUSION 
From  the  above  findings  it  can  be  concluded  that  the 
ethanolic extract of Symplocos racemosa possesses promising 
analgesic  and anti-inflammatory activities. The presence  of 
alkaloids,  glycosides,  phenolic  compounds,  carbohydrates, 
sterols  and  flavonoids  in  the  ethanolic  extract  of  the  plant 
under study may be responsible for these activities. Further 
pharmacodynamic investigations are required to understand 
the precise mechanism of action of Symplocos racemosa. 
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